Capital Purchase of Genetic Screening Processor and Panthera Punch

uation. Replacement is required with the newer version, the Revvity Genetic Service Processor (GSP) to ensure continuity of service provision, In addition to replacing the GSP, there is also a need to replace the current Panther multi puncher that is also at the very end of its lifespan

The Cardiff and Vale University Health Board have a requirement to replace the current Newborn Screening Analysers used for CHT and CF screening. The current equipment is at the end of life, as well as nearing discontin